Zimmer Biomet Holdings, Inc. provided earnings guidance for the full year ending December 31, 2022. For the period, the company projected Revenue to be $1 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
119.3 USD | +0.28% | -1.36% | -1.95% |
05-21 | Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target | MT |
05-13 | Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024, Payable on or About July 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.95% | 24.55B | |
-4.77% | 182B | |
+4.10% | 114B | |
-3.85% | 67.76B | |
+5.19% | 51.91B | |
+5.54% | 43.23B | |
+6.07% | 41.07B | |
+23.81% | 32.07B | |
+15.86% | 25B | |
-5.06% | 24.35B |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2022